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Abstract
Background and Purpose: Ischemic stroke is a destructive cerebrovascular disease and a leading cause of death. Yet, no
ideal neuroprotective agents are available, leaving prevention an attractive alternative. The extracts from the fruits of Lycium
barbarum (LBP), a Chinese anti-aging medicine and food supplement, showed neuroprotective function in the retina when
given prophylactically. We aim to evaluate the protective effects of LBP pre-treatment in an experimental stroke model.
Methods: C57BL/6N male mice were first fed with either vehicle (PBS) or LBP (1 or 10 mg/kg) daily for 7 days. Mice were
then subjected to 2-hour transient middle cerebral artery occlusion (MCAO) by the intraluminal method followed by 22-
hour reperfusion upon filament removal. Mice were evaluated for neurological deficits just before sacrifice. Brains were
harvested for infarct size estimation, water content measurement, immunohistochemical analysis, and Western blot
experiments. Evans blue (EB) extravasation was determined to assess blood-brain barrier (BBB) disruption after MCAO.
Results: LBP pre-treatment significantly improved neurological deficits as well as decreased infarct size, hemispheric
swelling, and water content. Fewer apoptotic cells were identified in LBP-treated brains by TUNEL assay. Reduced EB
extravasation, fewer IgG-leaky vessels, and up-regulation of occludin expression were also observed in LBP-treated brains.
Moreover, immunoreactivity for aquaporin-4 and glial fibrillary acidic protein were significantly decreased in LBP-treated
brains.
Conclusions: Seven-day oral LBP pre-treatment effectively improved neurological deficits, decreased infarct size and
cerebral edema as well as protected the brain from BBB disruption, aquaporin-4 up-regulation, and glial activation. The
present study suggests that LBP may be used as a prophylactic neuroprotectant in patients at high risk for ischemic stroke.
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Introduction
Ischemic stroke is a devastating cerebrovascular event and a
leading cause of death worldwide. Stroke sufferers may present
with various disabilities, including hemiplegia, dysesthesia, ataxia
and even visual impairment. Two relevant mechanisms promot-
ing these complications are extensive blood-brain barrier (BBB)
disruption [1,2] and cerebral edema [3,4]. After ischemic onset,
interruption of oxygen and glucose supply leads to cell death
cascades which consequently result in BBB breakdown and
cerebral edema [5]. Increased BBB permeability contributes to
vasogenic edema, causing intravascular fluid to move to the
surrounding brain parenchyma. This detrimental edema further
reduces blood flow supplying the neurons, causing irreversible
apoptosis [6,7]. Extensive interactions among these three
components become a vicious cycle, which accelerates brain
damage.
Present management for acute ischemic stroke includes
revascularization with thrombolytics and anti-edema therapy with
surgical decompression or diuretics [8,9,10]. In order to salvage
cell death, clinicians have also attempted to approach stroke
patients with combining neuroprotective agents such as oxygen
radical scavengers, NMDA receptor antagonists and MMP
inhibitors [3,11,12,13]; however, the outcomes are far less
satisfactory. Given the devastative effects and social burden of
stroke, preventive measures may be one of the many strategies in
stroke management.
Recent studies have reported that pre-administration of
neuroprotective agents are beneficial in experimental stroke
models. Adrenomedullin, rennin inhibitor aliskiren and Hawthorn
extract when given prophylactically showed protective effects in
suppressing cerebral edema and cell apoptosis as well as improving
neurological outcome [14,15,16]. In the present study, the extracts
from the fruit of Lycium barbarum (also named Wolfberry, Fructus
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Lycii, Gouqizi) which has been widely used in Chinese herbal
recipes for thousands of years was tested for its neuroprotective
effects in ischemic stroke.
Lycium barbarum is an important ingredient in traditional Chinese
medicine in promoting health and longevity as well as a food
supplement in the Western countries. Valuable components of
Lycium barbarum are not limited to its colored components
containing lutein and zeaxanthin, but include the polysaccharides
which constitute more than 40% of the fruit extract [17]. It has
been shown that pre-treatment using extracts of Lycium barbarum
containing mostly polysaccharides (LBP) could protect the
cultured primary cortical neurons from b-amyloid peptide
neurotoxicity [18,19]. We also found that LBP pre-treatment
could effectively protect the retina from neuronal death, glial
activation and oxidative stress in a murine retinal ischemia/
reperfusion model [20]. Taken together, we hypothesize that LBP
pre-treatment may be neuroprotective in ischemic stroke. In this
study, we evaluated the protective effects of LBP in a murine
transient cerebral ischemia/reperfusion model and further showed
that LBP pre-treatment could reduce cerebral edema and BBB
disruption in the early stage of stroke.
Materials and Methods
Ethics Statement
The use of animals in this study was conducted according to the
requirements of the Cap. 340 Animals (Control of Experiments)
Ordinance and Regulations, and all relevant legislation and Codes
of Practice in Hong Kong. All the experimental and animal
handling procedures were approved by the Faculty Committee on
the Use of Live Animals in Teaching and Research in The
University of Hong Kong (CULATR #1870-09).
Animals
C57BL/6N male mice (10–12 weeks old) used in the present
study were housed under diurnal lighting condition and allowed
free access to food and water.
Transient Cerebral Ischemia
Transient cerebral ischemia was induced by surgical occlusion
of the middle cerebral artery. The procedures of middle cerebral
artery occlusion (MCAO) were performed as previously described
[10,21]. Briefly, the mouse was anesthetized (induction with 2%
halothane in 70% nitrous oxide and 30% oxygen; maintenance
with 1% halothane in 70% nitrous oxide and 30% oxygen)
through a facemask [10,21]. An 8-0 filament coated with vinyl
polysiloxane (3M Dental Products, St. Paul, MN, USA) was
inserted into the right internal carotid artery to occlude right
middle cerebral artery at its origin. To confirm successful
obstruction and reperfusion of the artery, relative cerebral blood
flow (CBF) in the right middle cerebral artery core territory was
monitored through an optic fiber glued to the skull (2 mm
posterior and 6 mm lateral to bregma) and connected to a laser
Doppler flowmeter (Perimed, Ja¨rfa¨lla, Sweden). After filament
insertion, the gas anesthesia was continued for another 5 minutes
to ensure maintenance of ischemia. Then, the anesthesia was
removed and the animal was transferred to an incubator
(ThermoCareH intensive care unit system, ThermoCare Inc,
Incline Village, NV, USA) at 30uC. At 10 minutes before
reperfusion (i.e. 1 hour and 50 minutes after ischemia), the animal
was anesthetized again as before and the filament was removed at
2 hours after ischemia to allow reperfusion. The anesthesia was
continued for another 5 minutes after which the animal was kept
in an incubator for 4 hours. During the experiment, the rectal
temperature was kept by the heating pad at about 3761.5uC.
Lycium barbarum Polysaccharides Preparation and Drug
Treatment
Lycium barbarum polysaccharides (LBP) extracts were prepared as
previously described [19,22]. Briefly, the dried fruit of Lycium
barbarum (10 kg) were pulverized into small particles and saturated
in 95% ethanol. Subsequently, the remaining residue was filtered
and air-dried. The dry Lycium barbarum residue was then dissolved
in 70uC water, and the supernatant of which was concentrated,
precipitated with 95% ethanol and then vacuum dried to produce
the LBP extracts (2 g).
For treatment, LBP extracts were dissolved in phosphate-
buffered saline (PBS; 0.01M; pH 7.4). Mice were randomly
divided into 3 groups: PBS-treated group (Vehicle), 1 mg/kg
LBP-treated group (LBP1) and 10 mg/kg LBP-treated group
(LBP10). These dosages were chosen based on our previous in vivo
studies [22]. Animals were fed with LBP or PBS daily through a
gastric tube for 7 days prior to the induction of MCAO as Chinese
usually drink the soup containing Lycium barbarum for several days
[22].
Evaluation of Neurological Deficits, Infarct Size, and
Hemispheric Brain Swelling
Mice were evaluated for neurological deficits 22 hours after
reperfusion as previously described [10,21]. Briefly, mice were
scored in a double-blinded manner as follows: 0, no observable
neurological deficits (normal); 1, failure to extend opposite forepaw
(mild); 2, circling to the contralateral side (moderate); and 3, loss of
walking and righting reflex (severe). Mice were sacrificed immedi-
ately after scoring. Brains were cut into 6 coronal slices in 2-mm
thickness, stained with 2% 2,3,5-triphenyltetrazolium chloride
(TTC) (Sigma, St. Louis, MO, USA) at 37uC in dark to detect
ischemic area and subsequently fixed in 10% buffered formalin
overnight. The posterior surface of each brain slice was photo-
graphed and analyzed using a digital image analysis system
(SigmaScan Pro, SPSS, Chicago, IL, USA) for the determination
of infarct area, infarct volume and hemispheric swelling. Infarct
area and volume were estimated using the indirect method [10,21].
Hemispheric swelling was determined as 100%6(ipsilateral volu-
me2contralateral volume)/contralateral volume [8,10,21].
Terminal Deoxynucleotidyl Transferase Biotin-dUTP Nick-
End Labeling (TUNEL)
Apoptosis in brain sections was investigated by TUNEL assay
(DeadEnd Fluorometric TUNEL system, Promega, Madison, WI)
as previously described [23]. Sections were counterstained with
49,6-diamidino-2-phenylindole (DAPI) after the reaction to
validate the nuclear location of TUNEL-positive signal. Quanti-
fication of TUNEL-positive cells was analyzed along ipsilateral
ischemic penumbra area. At least ten microscopic fields (406
magnification) were counted in a double-blinded manner and
averaged in each section [24].
Tissue Processing and Immunohistochemical Analyses
Fixed brain slices were dehydrated and embedded in paraffin.
For immunohistochemical (IHC) analyses, 7-mm paraffin brain
sections were deparaffinized, rehydrated and blocked with normal
goat serum (mouse on mouse blocking solution for IgG). Sections
were then incubated with antibodies against IgG (1:200, MOM
kit, Vector Laboratories, Burlingame, CA, USA), occludin (1:50,
Zymed, CA, USA), aquaporin-4 (AQP4 1:500, Millipore, MA,
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USA), glial fibrillary acidic protein (GFAP 1:500, Dako, Denmark),
nitrotyrosine (NT 1:200, Upstate Biotechnology, NY, USA), poly
(ADP-ribose) (PAR 1:200, Alexis, Lausen, Switzerland) and matrix
metalloproteinase-9 (MMP-9 1:500, Abcam,MA, USA) overnight at
4uC. Subsequently, brain sections were incubated with correspond-
ing secondary antibody (1:200, Vector Laboratories, Burlingame,
CA, USA) for 45 minutes at room temperature. Diaminobenzadine
(DAB) (Zymed, CA, USA) staining was performed by incubating the
sections with 0.9% hydrogen peroxide and Vectastain ABC reagent
(Vector Laboratories, Burlingame, CA, USA) for 30 minutes at
room temperature. The immunoreactivity was visualized with DAB
staining and sections were counterstained with hematoxylin. Slides
were analyzed and scored according to the immunoreactivity
intensity and distribution as previously described [20,25]. Score 5
and score 1 indicated the highest immunoreactivity and the weakest
immunoreactivity, respectively. All procedures were carried out in a
double-blinded manner.
Water Content Measurement
A separate group of mice (n = 7) were used to evaluate the water
content. Mouse brains were harvested at 22 hours after reperfu-
sion for determination of water content in the cerebral tissue. Wet
and dry weight of cerebral hemispheres (ipsilateral and contralat-
eral) was measured and the corresponding water content was
calculated by the formula water content = 100% (wet weight2dry
weight)/wet weight [1,26].
Blood-Brain Barrier (BBB) Permeability
Another group of mice (n = 5) were operated to investigate the
integrity of BBB. BBB permeability was assessed by measuring
extravasated Evans blue (EB) dye. 0.1 ml of 4% EB (Sigma, USA)
in saline was injected through tail vein right after reperfusion.
Mice were sacrificed 22 hours after reperfusion by transcardial
perfusion of heparinized saline. The amount of EB in the cerebral
hemispheres was quantified at 630 nm by spectrofluorophotome-
try as previously described [1,2]
Western Blot Analysis
A new group of mice were used to analyze the expression of
occludin. Proteins were collected from ipsilateral hemispheres of
different groups as previously described with slight modification
[10]. Briefly, ipsilateral brain slice 3 and 4 were homogenized in
RIPA lysis buffer [20] and protein concentrations were measured
by protein assay (Bio-Rad, USA). Blots were blocked with 5% milk
for 1 hour at room temperature. Subsequently, blots were
incubated with antibody against occludin (1:500, Zymed, CA,
USA) overnight at 4uC and probed with the corresponding
secondary antibody (1:2000, Vector Laboratories, Burlingame,
CA, USA) for 1 hour at room temperature. Signals were
quantified by ImageJ (NIH, USA) and normalized against actin.
All procedures were carried out in a double-blinded manner.
Statistical Analysis
Data were presented as mean 6 SEM. Statistical analysis was
performed by one-way ANOVA with Bonferroni multiple
comparison tests in quantitative analysis and Kruskal-Wallis Test
followed by Dunn’s multiple comparison tests in qualitative
analysis (GraphPad Prism software, San Diego, CA, USA).
Statistical significance was assumed when P,0.05.
Results
Similar Relative CBF and Rectal Temperature
During experiments, the relative CBF in the right middle
cerebral artery core territory was monitored by laser Doppler
flowmeter to ensure successful occlusion and reperfusion of the
right middle cerebral artery. The rectal temperature was kept by
the heating pad at 3761.5uC. Our results indicated that mice in
the three experimental groups had very similar relative CBF and
rectal temperature during ischemia and reperfusion (Table 1),
suggesting that all the animals were subjected to similar degree of
ischemic insult and rectal temperature.
Improved Neurological Deficits
Mice were evaluated for neurological deficits at 22 hours after
reperfusion just before sacrifice. We observed more severe
neurological deficits in the vehicle group, while the neurological
scores were significantly improved by 10 mg/kg LBP pre-
treatment (P,0.05, Table 2).
Decreased Cerebral Infarct Size and Hemispheric
Swelling
TTC-staining results showed that the infarct area of brain slice
number 4 significantly dropped from about 36% in vehicle-treated
brains to approximately18% in both LBP groups (Figure 1B).
Moreover, the total infarct volume was also reduced in the mice
treated with LBP, especially with 10 mg/kg pre-treatment
(P,0.05 versus vehicle group, Figure 1C). Consistent with the
decreased infarct size, less hemispheric swelling was also observed
in ipsilateral cerebrum of LBP-treated mice (Figure 1D).
Fewer Apoptotic Cells in Ischemic Penumbra Area
Two-hour ischemia led to irreversible death of cerebral neurons.
Numerous TUNEL-positive cells were observed in vehicle-treated
brains in ischemic penumbral area. Yet, we found only a few in LBP-
treated brains (Figure 2). Quantification of TUNEL-positive cells
Table 1. Relative cerebral blood flow and body temperature of the mice during ischemia and after reperfusion.
Relative cerebral blood flow (%)
(Rectal temperature 6C)
5 min before ischemia 5 min after ischemia 5 min before reperfusion 5 min after reperfusion
Vehicle (n=8) 100
(36.960.2)
22.462.3 (37.160.1) 20.162.5
(38.561.2)
165.2621.2
(37.360.5)
LBP 1 (n =7) 100
(36.860.2)
22.264.4
(37.060.2)
21.963.6
(38.561.2)
126.8618.6
(37.260.7)
LBP 10 (n=7) 100
(37.060.1)
24.463.1
(37.260.1)
23.263.2
(38.460.6)
143.9631.5
(37.260.3)
doi:10.1371/journal.pone.0033596.t001
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showed a significant decline with pre-treatment of LBP (249.0 cells/
mm2 in LBP10 group vs. 422.2 cells/mm2 in vehicle group, P,0.05).
Less Brain Water Content
Decreased water content was found in ipsilateral hemispheres of
LBP-treated mice, which indicated less cerebral edema (P,0.05
LBP10 group vs. vehicle group, Figure 3A). Water content of the
contralateral hemispheres in all three groups was similar.
Alleviated Blood-Brain Barrier Breakdown after Transient
MCAO
Evans Blue dye leaked mainly into the ipsilateral hemispheres in
all experimental groups when compared with the minimal amount
in the contralateral side. LBP pre-treatment markedly decreased
the ipsilateral EB leakage, indicating that LBP reduced the BBB
permeability after transient MCAO (Figure 3B). This was further
confirmed by immunohistochemical analysis of IgG localization.
In vehicle-treated brains, the outline of blood vessels was
discontinuous and IgG immunoreactivity leaked outside the vessel
lumen, suggesting an elevated BBB permeability after MCAO
(Figure 3C). In line with the EB results, a smaller percentage of
leaky vessels was present in LBP-treated brains showing less BBB
disruption (P,0.001 versus vehicle group, Figure 3D).
Occludin is one of the proteins located at tight junctions which
played an important role in integrity of BBB. Previously, a
decreased level of occludin in ischemic brains after MCAO was
observed by Western blot [10,27]. The current Western blots
analyses revealed an up-regulation of occludin expression in both
LBP1 and LBP10 groups, supporting alleviated BBB breakdown
(P,0.05 LBP10 group versus vehicle group, Figure 4D). In
addition, LBP pre-treatment enhanced the immunoreactivity of
occludin along the outline of blood vessels (Figure 4A–C).
Down Regulation of Aquaporin-4 Expression
AQP4, a protein responsible for water transport in the brain,
was up-regulated by cerebral ischemic insult especially in the
astrocytic end-feet adjacent to the blood vessels [28]. However,
LBP pre-treatment profoundly suppressed the up-regulation of
AQP4 expression (Figure 5B, C). To semi-quantify the AQP4
expression, IHC scoring was performed. LBP10 group received a
score half of that in the vehicle group, verifying the reduction in
Table 2. Less severe neurological deficits in LBP-treated mice
after MCAO.
Distribution of neurological scores
Score 0 1 2 3 Mean±SEM
Vehicle (n=8) 0 2 4 2 2.0060.27
LBP 1 (n =7) 0 4 3 0 1.4360.20
LBP 10 (n=7) 0 6 1 0 1.1460.14*
*P,0.05 LBP10 vs. vehicle, Kruskal-Wallis test followed by Dunn’s Multiple
Comparison Test.
doi:10.1371/journal.pone.0033596.t002
Figure 1. Decreased infarct size and hemispheric swelling in LBP-treated brains after MCAO. (A) Representative photographs of coronal
brain slices stained with 2% TTC. Slice 1, most rostral; slice 5, most caudal. Note the smaller white regions indicating reduced infarct areas in LBP-
treated brains. Scale bar = 10 mm. LBP-treated brains showed significantly decreased infarct area % (B), infarct volume % (C) and hemispheric swelling
% (D) when compared with vehicle-treated brains. *P,0.05, ANOVA followed by Bonferroni’s test, n = 7 to 8 for all groups.
doi:10.1371/journal.pone.0033596.g001
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Figure 2. Fewer apoptotic cells in LBP group. The upper-left schematic diagram showed the area where TUNEL assay was analyzed (interaural
1.98 mm). The red shadow indicated the infarct area after MCAO. TUNEL-positive cells were counted in penumbral areas (black frames). (A) TUNEL. (B)
DAPI. (C) Merged images of TUNEL and DAPI (arrow heads). In LBP-treated groups, fewer TUNEL-positive cells were observed (C2 & C3) when
compared with vehicle group (C1). Scale bars = 25 mm. (D) Quantification of TUNEL-positive cells showing the decrease of apoptosis in LBP-treated
brains. * P,0.05, ANOVA followed by Bonferroni’s test, n = 5 each group.
doi:10.1371/journal.pone.0033596.g002
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AQP4 up-regulation (P,0.05 LBP10 group versus vehicle group,
Figure 5G).
Lower Glial Fibrillary Acidic Protein Activation
GFAP-stained astrocytes showed highly activated swollen
processes in ipsilateral penumbral area after MCAO (Figure 6A).
However, this activation was markedly reduced in LBP groups
(Figure 6B, C). Moreover, quantitative analysis showed that the
density of GFAP-positive cells was decreased to 38.6 cells/mm2 in
LBP10 group when compared with 85.6 cells/mm2 in the vehicle
group (P,0.05, Figure 6D).
Reduced Oxidative Stress
Nitrotyrosine (NT) is considered as a marker of nitrosative
stress. Increased immunoreactivity of NT was observed in vehicle-
treated brain (Figure 7A1), while LBP groups exhibited minimal
NT signal (Figure 7A2, A3). More importantly, the IHC score in
LBP10 group was below half of that in the vehicle-treated group,
verifying the reduction in NT expression (P,0.05, Figure 7C).
Poly (ADP-ribose) (PAR), activated by lipid peroxidation under
ischemic conditions, is also a marker of oxidative stress. A
profound PAR expression was noted in vehicle-treated brain
(Figure 7B1), suggesting an increased level of lipid peroxidation
Figure 3. Reduced water content and blood-brain barrier (BBB) disruption in LBP-treated cerebral hemispheres. (A) Water content in
vehicle and LBP-treated cerebral hemispheres 22 hours after reperfusion. White bars, contralateral hemisphere; filled bars, ipsilateral hemisphere.
*P,0.05, ANOVA followed by Bonferroni’s test, n = 7 each group. (B) Representative photographs of brains after Evans blue (EB) extravasation assay
(left). Scale bar = 10 mm. Leakage of EB (blue area) indicated BBB breakdown after MCAO. LBP-treated ipsilateral hemisphere showed decreased EB
extravasation (right). White bars, contralateral hemisphere; filled bars, ipsilateral hemisphere. *P,0.05, ANOVA followed by Bonferroni’s test, n = 5
each group. (C) Representative IgG IHC showing leaky blood vessels in ipsilateral penumbral areas (interaural 1.98 mm). IgG signal leaked outside the
blood vessel lumen (arrow head) in vehicle-treated brain. In LBP-treated brains, the outline of blood vessels was mostly intact and the IgG signal was
present inside the vessel lumen. Inserts, higher magnification of typical blood vessels. Scale bar = 200 mm, inserts scale bar = 25 mm. (D) Quantification
of blood vessel leakage in ipsilateral penumbral areas. Fewer leaky vessels were observed in LBP-treated brain when compared with the vehicle
group. ***P,0.001, ANOVA followed by Bonferroni’s test, n = 5 each group.
doi:10.1371/journal.pone.0033596.g003
Figure 4. Stronger expression of occludin. (A–C) Representative IHC showing occludin signal in blood vessels in ipsilateral penumbral areas
(interaural 1.98 mm). Occludin immunoreactivity was stronger in LBP10 group (arrow, C). Inserts, higher magnification of typical blood vessels. Scale
bar = 25 mm, inserts scale bar = 25 mm. (D) Western blots exhibiting higher level of occludin in LBP group. *P,0.05, ANOVA followed by Bonferroni’s
test, n = 3–5 for all groups.
doi:10.1371/journal.pone.0033596.g004
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after MCAO. LBP pre-treatment at 10 mg/kg markedly sup-
pressed the immunoreactivity of PAR (Figure 7B3). To semi-
quantify the PAR expression, IHC scoring was performed. LBP10
group received a score half of that in the vehicle group, confirming
the decline in lipid peroxidation (P,0.05 LBP10 group versus
vehicle group, Figure 7D).
Attenuated Expression of Matrix Metalloproteinase-9
MMP-9 immunoreactivity was significantly elevated after
MCAO in vehicle-treated brain (Figure 8A). Intense MMP-9
expression appeared mostly in endothelial cells in ipsilateral
penumbral areas. However, an attenuated level of MMP-9
immunoreactivity was noted in both LBP1 and LBP10 group
(Figure 8B, C) indicating that LBP could suppress the up-
regulation of MMP-9 after cerebral ischemia. Moreover, the IHC
score in vehicle, LBP1 and LBP10 were 4.660.4, 3.460.4 and
2.060.6 arbitrary units, respectively (P,0.05, Figure 8D).
Discussion
The fruit of Lycium barbarum (Gouqizi, Wolfberry, Fructus Lycii)
has been widely used as a traditional medicinal ingredient and
food supplement in China for decades. Also, it has become
increasingly popular in western countries as an anti-aging remedy
[29]. So far, no side effects or toxicity have been reported [29].
Recent investigations of Lycium barbarum have focused on its
valuable components, known as Lycium barbarum polysaccharides
(LBP), which constitutes more than 40% of the fruit extract. Major
components in LBP include glucose, arabinose, galacturonic acid
and galactose [19]. We showed in this study that LBP extracts
exerted significant neuroprotection when given prophylactically.
This may be one beneficial effect for patients at high risk for
ischemic stroke.
Besides LBP, other polysaccharide extracts have also been
shown to possess neuroprotective effects in cerebral ischemic
injuries. For instance, polysaccharides from Hyriopsis cumingii
exhibited neuroprotective functions through anti-apoptotic and
anti-oxidative activities in rat cerebral ischemia/reperfusion model
[30]; Ganoderma lucidum polysaccharides could protect against rat
cerebral ischemia by inhibiting apoptosis and the potential
mechanisms may be associated with the modulation of Bcl-2 and
caspase-3 pathway [31]; Cactus polysaccharides could reduce
neuronal apoptosis and oxidative stress in rat cerebral ischemia as
well [32]. Here, we report for the first time that LBP could
alleviate BBB disruption and cerebral edema resulting in a
significant neuroprotection after ischemic insult.
Figure 5. Decreased immunoreactivity of AQP4 in LBP-treated brain. (A–C) AQP4 IHC signals in swollen end-feet of astrocytes around
cerebral vessels in ipsilateral penumbral areas (interaural 1.98 mm). Note the intense AQP4 staining in vehicle-treated vessels after MCAO (arrows, A),
which was decreased in both LBP groups (B&C). (D–F) GFAP IHC using adjacent section to AQP4 IHC. Note the GFAP immunoreactivity located around
the same cerebral vessels as in the AQP4 immunoreactivity (arrows). Scale bar = 25 mm. (G) Semi-quantification of immunoreactivity of AQP4.
*P,0.05, Kruskal-Wallis followed by Dunn’s multiple comparison test, n = 5 each group.
doi:10.1371/journal.pone.0033596.g005
Figure 6. Fewer activated glial cells in LBP-treated brain. (A–C) Representative IHC showing activation of GFAP in ipsilateral penumbral areas
after MCAO (interaural 1.98 mm). Arrow heads, typical GFAP-positive astrocytes. Fewer GFAP-positive astrocytes were observed in LBP-treated brains
(B & C). Inserts, higher magnification of GFAP-positive astrocytes. Scale bar = 25 mm, inserts scale bar = 25 mm. (D) Quantification of GFAP-stained cells.
*P,0.05, ANOVA followed by Bonferroni’s test, n = 4–5 for all groups.
doi:10.1371/journal.pone.0033596.g006
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Acute excitotoxicity, oxidative stress and inflammation are three
primary mechanisms involved in cell death during ischemic stroke.
They markedly damage the neurovascular unit, which includes
neurons, glia and vascular components. [9]. Cell death within
infarct core might be irreversible without early reperfusion;
however, promising neuroprotective agents which could prevent
the neuronal damage bring hope to salvage the dying cells in the
penumbral area. Our previous study showed that pre-treatment of
LBP could protect the retinal ganglion cells from apoptosis in a
retinal ischemia model [20]. In the present investigation, improved
neurological deficits and smaller infarct size were observed in LBP-
treated mice. Moreover, we noted fewer apoptotic cells in the
penumbral area by TUNEL assay which was similar to our
findings in retina. Further observations on nitrosative stress and
lipid peroxidation (NT and PAR) suggested that the anti-oxidative
effects of LBP might contribute to smaller infarction and better
neurological outcome. We have also validated the neuroprotective
effects of LBP pre-treatment on cultured neurons and speculated
that the possible mechanism may be its inhibitory effects in JNK
and ERK signaling pathway [18,33].
Cerebral ischemia and reperfusion triggers a cascade of cellular
events including cell death, oxidative stress and inflammation
which all contribute to the breakdown of BBB [9]. BBB disruption
further aggravates either vasogenic edema or hemorrhagic
Figure 7. LBP pre-treatment reduced both nitrosative stress and lipid peroxidation in cerebral ischemic penumbra after MCAO. (A1–
A3) Immunohistochemistry of nitrotyrosine (NT). Increased immunoreactivity of NT was noted in vehicle-treated brains after MCAO (arrows, A1).
However, minimal NT signal was found in LBP groups (A2 & A3). (B1–B3) Immunohistochemistry of poly(ADP-ribose) (PAR). A profound PAR
expression was observed in vehicle-treated brains (arrows, B1). With LBP treatment (LBP10), PAR immunoreactivity was much reduced (B3). (C & D)
Semi-quantification of IHC (C, NT; D, PAR). * P,0.05, Kruskal-Wallis followed by Dunn’s multiple comparison test, n = 5–7 for all groups. Scale
bars = 25 mm.
doi:10.1371/journal.pone.0033596.g007
Figure 8. Decreased immunoreactivity of MMP-9 in LBP-treated brain. (A–C) MMP-9 IHC signals in endothelial cells along vessels in
ipsilateral penumbral areas (interaural 1.98 mm). Note the intense MMP-9 staining in vehicle-treated vessels after MCAO (arrow, A), which was
reduced in both LBP groups (arrows, B&C). Scale bar = 25 mm. (D) Semi-quantification of immunoreactivity of MMP-9. *P,0.05, LBP10 vs. Vehicle,
Kruskal-Wallis followed by Dunn’s multiple comparison test, n = 5 each group.
doi:10.1371/journal.pone.0033596.g008
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transformation which leads to severe neurological deficits [1]. In
our study, we investigated the integrity of BBB by Evans blue assay
and IgG immunohistochemistry which both revealed a decreased
permeability of BBB after LBP pre-treatment. Furthermore, less
disrupted tight junctions indicated by higher expression of
occludin in LBP-treated brains supported the current findings.
These results were consistent with our previous data which showed
LBP pre-treatment could protect the blood-retinal barrier
disruption after retinal ischemia/reperfusion injury [20]. It is
widely accepted that matrix metalloproteinases (MMP) are major
enzymes positively associated with disruption of BBB after
ischemic injuries. Elevated MMP-9 expression was observed
within the first three days after ischemic stroke and it exhibited
close connection with the extent of BBB breakdown [34]. In line
with previous studies [35,36], an increased level of MMP-9
immunoreactivity was noted in vehicle-treated brains at 24 hours
after cerebral ischemia in our investigation. As expected, MMP-9
expression was mainly located in the endothelial cells along the
vessels in penumbral areas. With 7-day LBP pre-treatment, the
elevated expression of MMP-9 was markedly attenuated, indicat-
ing that the protective effects of LBP on BBB disruption might
partially relate to the down-regulation of MMP-9.
Cerebral edema is a detrimental feature after ischemic stroke
and one of the impact factors of clinical deterioration within the
first 24 hours after stroke onset [37]. Swelling caused by edema
brings harmful effects on adjacent non-ischemic tissues due to the
fixed volume of the skull and further affects the prognosis of
patients [4,38]. Here, we observed that pre-treatment of LBP
reduced cerebral swelling and water content in the injured
hemisphere, suggesting that LBP is helpful to lessen cerebral
edema after MCAO. Apart from these findings, we further
investigated the effects of LBP on AQP4. AQP4 is a principal
water-channel protein responsible for water movement in the
brain parenchyma. Multiple studies have shown that the
expression of AQP4 is up-regulated after cerebral ischemic injuries
[10,28,39]. Lately, AQP4 has become a potential therapeutic
target to treat cerebral edema during ischemic stroke [39]. Our
study revealed lower immunoreactivity of AQP4 in LBP-treated
brains, illustrating that the anti-edema effects of LBP may partly
act through its modulation on AQP4 expression.
It should be noted that the relative CBF measurement in this
study indicated only the blood flow data obtained from a spot at
the center of the middle cerebral artery territory i.e. ischemic core.
In fact, there is a possibility that blood flow in the penumbra is
altered by LBP pre-treatment. However, at this point, there is not
enough evidence in the current study to show that blood flow in
the penumbra is altered by LBP pre-treatment. Further investi-
gation is necessary to explore the effects of LBP in improving
cerebral blood flow after stroke.
Taken together, the neuroprotective effects of LBP pre-
treatment on ischemic stroke include anti-apoptosis, conservation
of BBB integrity and alleviation of cerebral edema. Based on the
current results, these protective effects might act through anti-
oxidation and down-regulation of MMP-9. The present study
clearly suggests the beneficial prophylactic effects of LBP against
ischemic damage and cerebral edema in a murine experimental
stroke model. Although the active ingredients of LBP in protecting
ischemic stroke remains unknown, LBP pre-stroke dosing regimen
may have the potential in translating into clinical situations for
high-risk patients.
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